These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2476243)
21. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. van Loveren H; Meade R; Askenase PW J Exp Med; 1983 May; 157(5):1604-17. PubMed ID: 6602201 [TBL] [Abstract][Full Text] [Related]
23. Delayed-type hypersensitivity against Semliki Forest virus in mice. Kraaijeveld CA; Harmsen M; Khader Boutahar-Trouw B Infect Immun; 1979 Feb; 23(2):219-23. PubMed ID: 422238 [TBL] [Abstract][Full Text] [Related]
24. T-cell hybridomas recognizing the envelope proteins of Semliki forest virus: their sensitivity to endo/lysosomal protease and the antigenicity. Watari E; Yokomuro K Jpn J Med Sci Biol; 1992 Jun; 45(3):113-25. PubMed ID: 1283995 [TBL] [Abstract][Full Text] [Related]
25. Distinct human T cell repertoires mediate immediate and delayed-type hypersensitivity to the Trichophyton antigen, Tri r 2. Woodfolk JA; Sung SS; Benjamin DC; Lee JK; Platts-Mills TA J Immunol; 2000 Oct; 165(8):4379-87. PubMed ID: 11035075 [TBL] [Abstract][Full Text] [Related]
26. Suppression of hapten-specific delayed-type hypersensitivity responses in mice by idiotype-specific suppressor T cells after administration of anti-idiotypic antibodies. Yamamoto H; Nonaka M; Katz DH J Exp Med; 1979 Oct; 150(4):818-29. PubMed ID: 92519 [TBL] [Abstract][Full Text] [Related]
27. The Semliki Forest virus E2 gene as a virulence determinant. Santagati MG; Määttä JA; Itäranta PV; Salmi AA; Hinkkanen AE J Gen Virol; 1995 Jan; 76 ( Pt 1)():47-52. PubMed ID: 7844541 [TBL] [Abstract][Full Text] [Related]
28. Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus. Ariel N; Lehrer S; Elhanaty E; Sabo T; Brodt P; Lachmi B; Katz D; Levin R; Grosfeld H; Velan B Arch Virol; 1990; 113(1-2):99-106. PubMed ID: 1696808 [TBL] [Abstract][Full Text] [Related]
29. HCV core protein-expressing DNA vaccine induces a strong class I-binding peptide DTH response in mice. Acosta-Rivero N; Dueñas-Carrera S; Alvarez-Lajonchere L; Morales-Grillo J Biochem Biophys Res Commun; 2004 Feb; 314(3):781-6. PubMed ID: 14741703 [TBL] [Abstract][Full Text] [Related]
30. Arsonate-specific murine T cell clones. II. Delayed-type hypersensitivity induced by P-azobenzenearsonate-L-tyrosine (ABA-Tyr). Morita CT; Goodman JW; Lewis GK J Immunol; 1985 May; 134(5):2894-9. PubMed ID: 2580007 [TBL] [Abstract][Full Text] [Related]
31. Role of interferon-gamma in T-cell responses to Semliki Forest virus-infected murine brain cells. Tomkins PT; Ward GA; Morris AG Immunology; 1988 Mar; 63(3):355-62. PubMed ID: 2832313 [TBL] [Abstract][Full Text] [Related]
32. The significance of the 3'-nontranslated region and E2 amino acid mutations in the virulence of Semliki Forest virus in mice. Santagati MG; Määttä JA; Röyttä M; Salmi AA; Hinkkanen AE Virology; 1998 Mar; 243(1):66-77. PubMed ID: 9527916 [TBL] [Abstract][Full Text] [Related]
33. Modulation of adjuvant-enhanced delayed-type hypersensitivity by the interferon inducers poly I:C and Newcastle disease virus. Kraaijeveld CA; Kamphuis W; Benaissa-Trouw BJ; Harmsen M; Snippe H Int Arch Allergy Appl Immunol; 1986; 79(1):86-9. PubMed ID: 2416698 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies specific for Semliki Forest virus replicase protein nsP2. Kujala P; Rikkonen M; Ahola T; Kelve M; Saarma M; Kääriäinen L J Gen Virol; 1997 Feb; 78 ( Pt 2)():343-51. PubMed ID: 9018056 [TBL] [Abstract][Full Text] [Related]
35. Studies on linear epitopes of Semliki Forest virus in protection studies against lethal challenge virus infection. Truyen U; Kaaden OR Zentralbl Veterinarmed B; 1991 Aug; 38(6):463-7. PubMed ID: 1719714 [TBL] [Abstract][Full Text] [Related]
36. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen. Sewell WA; Munoz JJ; Scollay R; Vadas MA J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132 [TBL] [Abstract][Full Text] [Related]
37. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses. Miller SD; Butler LD J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929 [TBL] [Abstract][Full Text] [Related]
38. B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest Virus encephalomyelitis. Smith-Norowitz TA; Sobel RA; Mokhtarian F Cell Immunol; 2000 Feb; 200(1):27-35. PubMed ID: 10716880 [TBL] [Abstract][Full Text] [Related]
39. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine. Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413 [TBL] [Abstract][Full Text] [Related]
40. Influenza, but not HIV-specific CTL epitopes, elicits delayed-type hypersensitivity (DTH) reactions in HIV-infected patients. Ruiz-Riol M; Mothe B; Gandhi RT; Bhardwaj N; Scadden DT; Sanchez-Merino V; Brander C Eur J Immunol; 2013 Jun; 43(6):1545-54. PubMed ID: 23504637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]